International
The Morning Science

What science found today

‹
 

Research

Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy

Science · By Wenjie Wang, Jiaxin Guo, Hong Han, Dan Yuan & Junfeng Shi ·

The Brief

  • A Science Advances paper, 'Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy', was published in Volume 12, Issue 47 in November 2026.
  • The work describes membrane-confined self-assembly as a way to achieve localized bioorthogonal prodrug activation.
  • The stated goal is selective cancer therapy.

Why it matters

The approach aims to confine prodrug activation to a specific location, which could help limit drug effects on healthy tissue. Science readers in chemical biology and cancer drug development may find the method relevant.

Who’s affected

  • chemical biologists
  • cancer drug researchers

Science Advances, Volume 12, Issue 47 , November 2026.

Timeline

  1. Research published in Science Advances (Volume 12, Issue 47)

  2. science.org

    Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy

How do you feel about this?

0 Comments

    Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy – The Morning Science